G Siva Kumar

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 4

Top Topics

Traumatic Brain Injury

Mild Cognitive Impairment

Top Venues

Diseases (Basel, Switzerland)

Future medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Ramakrishna Kakarla, Praditha Karuturi, Queen Siakabinga, Gajendra T A, Sairam Krishnamurthy, Shreya Singh, Sonia Kumari, G Siva Kumar, M Elizabeth Sobhia, Sachchida Nand Rai
Indole-3 Carbinol and Diindolylmethane Mitigated β-Amyloid-Induced Neurotoxicity and Acetylcholinesterase Enzyme Activity: In Silico, In Vitro, and Network Pharmacology Study. Diseases (Basel, Switzerland) 12 (8) (2024)
Ramakrishna Kakarla, Praditha Karuturi, Queen Siakabinga, Gajendra T A, Sairam Krishnamurthy, Shreya Singh, Sonia Kumari, G Siva Kumar, M Elizabeth Sobhia, Sachchida Nand Rai
Indole-3 Carbinol and Diindolylmethane Mitigated β-Amyloid-Induced Neurotoxicity and Acetylcholinesterase Enzyme Activity: In Silico, In Vitro, and Network Pharmacology Study. Diseases (Basel, Switzerland) 12 (8) (2024)
Ramakrishna Kakarla, Praditha Karuturi, Queen Siakabinga, Gajendra T A, Sairam Krishnamurthy, Shreya Singh, Sonia Kumari, G Siva Kumar, M Elizabeth Sobhia, Sachchida Nand Rai
Indole-3 Carbinol and Diindolylmethane Mitigated β-Amyloid-Induced Neurotoxicity and Acetylcholinesterase Enzyme Activity: In Silico, In Vitro, and Network Pharmacology Study. Diseases (Basel, Switzerland) 12 (8) (2024)
Masilamani Elizabeth Sobhia, G Siva Kumar, Srikanth Sivangula, Ketan Ghosh, Harmanpreet Singh, Thongtinlal Haokip, Joseph Gibson
Rapid structure-based identification of potential SARS-CoV-2 main protease inhibitors. Future medicinal chemistry 13 (17) (2021)